BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K
1316 results:

  • 1. EGFR and pi3k Signalling Pathways as Promising Targets on Circulating Tumour Cells from Patients with Metastatic gastric Adenocarcinoma.
    Piper AK; Penney C; Holliday J; Tincknell G; Ma Y; Napaki S; Pantel K; Brungs D; Ranson M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791602
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via pi3k/AKT signaling pathway.
    Lu Y; Wang H; Chen S; Yang B; Li Y; Li Y
    J Cancer Res Clin Oncol; 2024 May; 150(5):244. PubMed ID: 38717526
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via pi3k/Akt signaling pathway.
    Cheng L; Li X; Dong W; Yang J; Li P; Qiang X; Yin J; Guo L
    J Cancer Res Clin Oncol; 2024 May; 150(5):230. PubMed ID: 38703300
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of expression level of BANCR, MALAT1 and FER1L4 and their target genes in coumarin-treated AGS cell line.
    Shafaee Arani S; Nejati M; Rastgoufar S; Raisi A; Eshraghi R; Ostadian A; Matini AH; Rahimain N; Mirzaei H
    Pathol Res Pract; 2024 May; 257():155291. PubMed ID: 38643553
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Molecular Landscape of gastric cancers for Novel Targeted Therapies from Real-World Genomic Profiling.
    Yamamoto H; Arai H; Oikawa R; Umemoto K; Takeda H; Mizukami T; Kubota Y; Doi A; Horie Y; Ogura T; Izawa N; Moore JA; Sokol ES; Sunakawa Y
    Target Oncol; 2024 May; 19(3):459-471. PubMed ID: 38613733
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Network Pharmacology Analysis of Liquid-Cultured
    Wang Z; Wang R; Na Z; Liang S; Wu F; Xie H; Zhang X; Xu W; Wang X
    Molecules; 2024 Apr; 29(7):. PubMed ID: 38611946
    [No Abstract]    [Full Text] [Related]  

  • 7. NTRK3 exhibits a pro-oncogenic function in upper tract urothelial carcinomas.
    Lim LM; Lee YC; Lin TW; Hong ZX; Hsu WC; Ke HL; Hwang DY; Chung WY; Li WM; Lin HH; Kuo HT; Huang AM
    Kaohsiung J Med Sci; 2024 May; 40(5):445-455. PubMed ID: 38593276
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Exploring the evolutionary mechanism of hepatitis B and gastric cancer based on Mendelian randomization combined with bioinformatics analysis.
    Cai H; Huang T; Zheng B; Zhu X; Zhou L; Wu J; Xu Y; Huang S; Huang Y; Liu T
    Medicine (Baltimore); 2024 Apr; 103(14):e37645. PubMed ID: 38579038
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Nanoparticles for Augmenting Therapeutic Potential and Alleviating the Effect of Di(2-ethylhexyl) Phthalate on gastric cancer.
    Huang HL; Chen KW; Liao HW; Wang LY; Peng SL; Lai CH; Lin YH
    ACS Appl Mater Interfaces; 2024 Apr; 16(15):18285-18299. PubMed ID: 38574184
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the pi3k/Akt pathway.
    Yang F; Zheng Y; Luo Q; Zhang S; Yang S; Chen X
    BMC Cancer; 2024 Apr; 24(1):408. PubMed ID: 38566039
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer.
    Zhong Q; Hong W; Xiong L
    Aging (Albany NY); 2024 Mar; 16(7):6163-6187. PubMed ID: 38552217
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nobiletin targets SREBP1/ACLY to induce autophagy-dependent cell death of gastric cancer cells through pi3k/Akt/mTOR signaling pathway.
    Chen M; Li H; Zheng S; Shen J; Chen Y; Li Y; Yuan M; Wu J; Sun Q
    Phytomedicine; 2024 Jun; 128():155360. PubMed ID: 38547624
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. USP50 regulates NLRP3 inflammasome activation in duodenogastric reflux-induced gastric tumorigenesis.
    Zhao C; Mu M; Li X; Dong Z; Wang J; Yao C; Zheng J; Sun X; Yu J
    Front Immunol; 2024; 15():1326137. PubMed ID: 38469295
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.
    Weidner P; Saar D; Söhn M; Schroeder T; Yu Y; Zöllner FG; Ponelies N; Zhou X; Zwicky A; Rohrbacher FN; Pattabiraman VR; Tanriver M; Bauer A; Ahmed H; Ametamey SM; Riffel P; Seger R; Bode JW; Wade RC; Ebert MPA; Kragelund BB; Burgermeister E
    Cancer Lett; 2024 Apr; 588():216783. PubMed ID: 38462034
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PXMP4 promotes gastric cancer cell epithelial-mesenchymal transition via the pi3k/AKT signaling pathway.
    Li W; Dong X; Wan Z; Wang W; Zhang J; Mi Y; Li R; Xu Z; Wang B; Li N; He G
    Mol Biol Rep; 2024 Feb; 51(1):350. PubMed ID: 38401002
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pectolinarigenin regulates the tumor-associated proteins in AGS-xenograft BALB/c nude mice.
    Lee HJ; Kwon YS; Lee JH; Moon YG; Choi J; Hyun M; Tak TK; Kim JH; Heo JD
    Mol Biol Rep; 2024 Feb; 51(1):305. PubMed ID: 38361124
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Subtle structural alteration in indisulam switches the molecular mechanisms for the inhibitory effect on the migration of gastric cancer cells.
    Hou C; Wu X; Shi R; Xing X; Tian S; Eléouët M; Qiao C; Ma J; Xu G
    Biomed Pharmacother; 2024 Mar; 172():116259. PubMed ID: 38359488
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparative analysis of KRAS4a and KRAS4b splice variants reveals distinctive structural and functional properties.
    Whitley MJ; Tran TH; Rigby M; Yi M; Dharmaiah S; Waybright TJ; Ramakrishnan N; Perkins S; Taylor T; Messing S; Esposito D; Nissley DV; McCormick F; Stephen AG; Turbyville T; Cornilescu G; Simanshu DK
    Sci Adv; 2024 Feb; 10(7):eadj4137. PubMed ID: 38354232
    [No Abstract]    [Full Text] [Related]  

  • 19. Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on
    Cheng FE; Li Z; Bai X; Jing Y; Zhang J; Shi X; Li T; Li W
    Aging (Albany NY); 2024 Feb; 16(4):3386-3403. PubMed ID: 38345573
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate pi3k-Akt-mTOR pathway and is a therapeutic target.
    Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
    Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 66.